ClinicalTrials.Veeva

Menu

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease

F

Firat Ergin

Status

Completed

Conditions

Sepsis Newborn

Treatments

Diagnostic Test: Neutrophil to lymphosit ratio

Study type

Observational

Funder types

Other

Identifiers

NCT03923543
(2018/12- 7

Details and patient eligibility

About

The use of neutrophil lymphocyte ratio is useful for the detection of infection status in newborns after surgery

Full description

The use of neutrophil lymphocyte ratio is useful for the detection of infection status in newborns after surgery and we compare this with other acute phase reactants

Enrollment

60 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • newborn to be operated with the diagnosis of congenital heart disease

Exclusion criteria

  • age older than 1 month not to be operated

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems